PT  - JOURNAL ARTICLE
AU  - Mario M. Leitao
AU  - Xi Cheng
AU  - Anne L. Hamilton
AU  - Nadeem A. Siddiqui
AU  - Ina Jurgenliemk-Schulz
AU  - Sven Mahner
AU  - Elisabeth Åvall-Lundqvist
AU  - Kidong Kim
AU  - Gilles Freyer
TI  - Gynecologic Cancer InterGroup (GCIG) Consensus Review for Vulvovaginal Melanomas
AID  - 10.1097/IGC.0000000000000198
DP  - 2014 Nov 01
TA  - International Journal of Gynecologic Cancer
PG  - S117--S122
VI  - 24
IP  - Supp 3
4099  - http://ijgc.bmj.com/content/24/Supp_3/S117.short
4100  - http://ijgc.bmj.com/content/24/Supp_3/S117.full
SO  - Int J Gynecol Cancer2014 Nov 01; 24
AB  - Abstract Vulvovaginal melanomas are rare tumors that account for a small fraction of all vulvovaginal cancers. Biologically, they seem to be similar to mucosal and acral melanomas of other sites. There are limited data specific to vulvovaginal melanomas, especially regarding systemic therapies. Most treatment decisions are based on extrapolation from data regarding cutaneous melanomas of other sites. It is reasonable to follow already established guidelines from other professional groups and societies. Outcomes tend to be worse compared with cutaneous melanomas likely because of the later presentation and physical biological characteristics of these tumors.